Anna Sureda Balari

75PUBLICATIONS
495CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyMedical genetics (excl. cancer genetics)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Sep 02, 2026
Teclistamab and Daratumumab Immune-Based Doublet Therapy for Relapsed/Refractory Multiple Myeloma: the TRIMM-2 Study.

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|Aug 11, 2026
Defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from EBMT Global Committee.

|Jul 25, 2026
Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes.

|Jul 24, 2026
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

|Jul 19, 2026
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study.

Pageof 13

Frequent Collaborators

14 joint publications

Ali Bazarbachi

11 joint publications

Donal P McLornan

10 joint publications

Albert Ortiol

10 joint publications

Raffaella Greco